Filtered Listing Testing

Diane Bovenkamp, Ph.D., Vice President of Scientific Affairs at BrightFocus Foundation answered reader questions about how to prevent or treat vision problems, what resources you can turn to for help, and current research on Alzheimer’s and eyesight.

BrightFocus Foundation, a nonprofit and premier source of research funding to defeat Alzheimer’s, macular degeneration, and glaucoma, today was acknowledged as the catalyst behind a major advance in drug development for Alzheimer’s disease.

A panel of leading researchers and policy experts has released five key recommendations for public and private sector leaders to better support people with dementia living in their own home.

Ruchira Singh and colleagues at the University of Rochester and worldwide have shown that even rare forms of macular degeneration develop in ways similar to AMD, with drusen formation and extracellular proteins. The goal ahead: effective early treatment approaches.

Leaders Engaged on Alzheimer’s Disease (LEAD Coalition) released an in-depth Issue Brief on Medicaid and Dementia, detailing how the program is indispensable for many individuals with significant health care needs, and why the program should not be cut.

Using atomic-level imaging, Paul Seidler, UCLA, looks at how tau protein creates tangles in Alzheimer’s—and how to stop it with well-designed drugs. The work is supported by a partnership between BrightFocus and Alzheimer’s Los Angeles. .